Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular basis of human immunodeficiency virus type 1 drug resistance: Overview and recent developments
Luis Menéndez‐Arias
Antiviral Research (2013) Vol. 98, Iss. 1, pp. 93-120
Closed Access | Times Cited: 198

Showing 1-25 of 198 citing articles:

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 431
Human Immunodeficiency Virus (HIV)

Transfusion Medicine and Hemotherapy (2016) Vol. 43, Iss. 3, pp. 203-222
Open Access | Times Cited: 294
Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 7, pp. 2849-2878
Closed Access | Times Cited: 289
Antiviral drug resistance as an adaptive process
Kristen K. Irwin, Nicholas Renzette, Timothy F. Kowalik, et al.
Virus Evolution (2016) Vol. 2, Iss. 1, pp. vew014-vew014
Open Access | Times Cited: 202
Update and latest advances in antiretroviral therapy
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 140
Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses
Yue Ma, Estrella Frutos-Beltrán, Dongwei Kang, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 7, pp. 4514-4540
Open Access | Times Cited: 134
Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation
Spandana Inugala, Basanth Babu Eedara, Sharath Sunkavalli, et al.
European Journal of Pharmaceutical Sciences (2015) Vol. 74, pp. 1-10
Closed Access | Times Cited: 167
Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance
Luis Menéndez‐Arias, Mar Álvarez, Beatriz Pacheco
Current Opinion in Virology (2014) Vol. 8, pp. 1-9
Closed Access | Times Cited: 154
Retroviral proteases and their roles in virion maturation
Jan Konvalinka, Hans‐Georg Kräusslich, Bárbara Müller
Virology (2015) Vol. 479-480, pp. 403-417
Open Access | Times Cited: 133
Viral reverse transcriptases
Luis Menéndez‐Arias, Alba Sebastián-Martín, Mar Álvarez
Virus Research (2016) Vol. 234, pp. 153-176
Open Access | Times Cited: 103
Coronaviruses Resistant to a 3C-Like Protease Inhibitor Are Attenuated for Replication and Pathogenesis, Revealing a Low Genetic Barrier but High Fitness Cost of Resistance
Xufang Deng, Sarah E. St. John, Heather L. Osswald, et al.
Journal of Virology (2014) Vol. 88, Iss. 20, pp. 11886-11898
Open Access | Times Cited: 96
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities
Lin Sun, Tianguang Huang, Alexej Dick, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112085-112085
Open Access | Times Cited: 86
HIV Protease: Historical Perspective and Current Research
Irene T. Weber, Yuan‐Fang Wang, Robert W. Harrison
Viruses (2021) Vol. 13, Iss. 5, pp. 839-839
Open Access | Times Cited: 73
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
János András Mótyán, Mohamed Mahdi, Gyula Hoffka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3507-3507
Open Access | Times Cited: 63
Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges
Shaoqing Du, Xueping Hu, Luis Menéndez‐Arias, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101053-101053
Closed Access | Times Cited: 14
Antiviral Characteristics of GSK1265744, an HIV Integrase Inhibitor Dosed Orally or by Long-Acting Injection
Tomokazu Yoshinaga, Masanori Kobayashi, Takahiro Seki, et al.
Antimicrobial Agents and Chemotherapy (2014) Vol. 59, Iss. 1, pp. 397-406
Open Access | Times Cited: 93
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection
Luis Menéndez‐Arias, Mar Álvarez
Antiviral Research (2013) Vol. 102, pp. 70-86
Closed Access | Times Cited: 92
Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds
Inês Moranguinho, Nuno Taveira, Inês Bártolo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5905-5905
Open Access | Times Cited: 17
Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 6
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase
Vijay P. Sonar, Angela Corona, Simona Distinto, et al.
European Journal of Medicinal Chemistry (2017) Vol. 130, pp. 248-260
Open Access | Times Cited: 59
RNA Viruses and RNAi: Quasispecies Implications for Viral Escape
John B. Presloid, Isabel S. Novella
Viruses (2015) Vol. 7, Iss. 6, pp. 3226-3240
Open Access | Times Cited: 52
Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors
Xiangyi Jiang, Gaochan Wu, Waleed A. Zalloum, et al.
RSC Advances (2019) Vol. 9, Iss. 50, pp. 28961-28986
Open Access | Times Cited: 51
Prenylated phloroglucinols from Hypericum scruglii, an endemic species of Sardinia (Italy), as new dual HIV-1 inhibitors effective on HIV-1 replication
Cinzia Sanna, Monica Scognamiglio, Antonio Fiorentino, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0195168-e0195168
Open Access | Times Cited: 50
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus
Enzo Tramontano, Angela Corona, Luis Menéndez‐Arias
Antiviral Research (2019) Vol. 171, pp. 104613-104613
Open Access | Times Cited: 50
Winning the Tug-of-War Between Effector Gene Design and Pathogen Evolution in Vector Population Replacement Strategies
John M. Marshall, Robyn Raban, Nikolay P. Kandul, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top